Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Darell L. Hunt
Small Molecule Chloropyramine Hydrochloride (C4) Targets the Binding Site of Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor 3 and Suppresses Breast Cancer Growth in Vivo
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Related publications
The Effects of Neoadjuvant Anastrozole and Tamoxifen on Circulating Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor 1 in Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
A Small Molecule Inhibitor, 1,2,4,5-Benzenetetraamine Tetrahydrochloride, Targeting the Y397 Site of Focal Adhesion Kinase Decreases Tumor Growth
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
A Recombinant Mutant Vascular Endothelial Growth Factor-C That Has Lost Vascular Endothelial Growth Factor Receptor-2 Binding, Activation, and Vascular Permeability Activities
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome
Archives of Rheumatology
Rheumatology
Vascular Endothelial Growth Factor Suppresses Dendritic Cells Function of Human Prostate Cancer
OncoTargets and Therapy
Oncology
Pharmacology
The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis
Cancer Research
Cancer Research
Oncology
Estrogen-Related Receptor Alpha Induces the Expression of Vascular Endothelial Growth Factor in Breast Cancer Cells
Journal of Steroid Biochemistry and Molecular Biology
Molecular Medicine
Cell Biology
Molecular Biology
Biochemistry
Endocrinology
Clinical Biochemistry
Metabolism
Diabetes
Phosphatidylinositol 3-Kinase Signaling Mediates Angiogenesis and Expression of Vascular Endothelial Growth Factor in Endothelial Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients With Refractory Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
